Clinical Trial Update: Diabetes Islet Preservation Immune Treatment [Phase 1, Phase 2]

View source ↗

Summary

The clinical trial on Diabetes Islet Preservation Immune Treatment (Phase 1/2) has been withdrawn. It targeted type 1 diabetes and related hypoglycemia in an au…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypoglycemia
• Type 1 Diabetes Mellitus

Snippet

Sponsor: Camillo Ricordi and Jay Skyler | Conditions: Diabetes Mellitus, Type 1, Hypoglycemia | Phase 1, Phase 2 | Status: WITHDRAWN